Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury.

Maroni L, Pinto C, Giordano DM, Saccomanno S, Banales JM, Spallacci D, Albertini MC, Orlando F, Provinciali M, Milkiewicz M, Melum E, Ciriza IL, Milkiewicz P, Rychlicki C, Trozzi L, Scarpelli M, Benedetti A, Svegliati Baroni G, Marzioni M.

Hepatology. 2018 Dec 18. doi: 10.1002/hep.30466. [Epub ahead of print]

PMID:
30561764
2.

Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis.

Ong J, Bath MF, Swift C, Al-Naeeb Y.

Gastroenterol Hepatol Bed Bench. 2018 Fall;11(4):277-283. Review.

3.

Animal models of cholestasis: An update on inflammatory cholangiopathies.

Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M, Fabris L.

Biochim Biophys Acta Mol Basis Dis. 2018 Aug 11. pii: S0925-4439(18)30274-6. doi: 10.1016/j.bbadis.2018.07.025. [Epub ahead of print] Review.

PMID:
30398152
4.

Etiopathogenesis of autoimmune hepatitis.

Floreani A, Restrepo-Jiménez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, Bowlus CL, Gershwin ME, Anaya JM.

J Autoimmun. 2018 Dec;95:133-143. doi: 10.1016/j.jaut.2018.10.020. Epub 2018 Oct 29. Review.

PMID:
30385083
5.

Metabolomic analysis of cholestatic liver damage in mice.

Yang R, Zhao Q, Hu DD, Xiao XR, Huang JF, Li F.

Food Chem Toxicol. 2018 Oct;120:253-260. doi: 10.1016/j.fct.2018.07.022. Epub 2018 Jul 20.

PMID:
30009888
6.

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids.

Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, Wahlström A, Ståhlman M, Thüringer A, Kashofer K, Stojakovic T, Marschall HU, Trauner M.

Gut. 2018 Sep;67(9):1683-1691. doi: 10.1136/gutjnl-2017-314553. Epub 2018 Apr 10.

7.

Paracrine cellular senescence exacerbates biliary injury and impairs regeneration.

Ferreira-Gonzalez S, Lu WY, Raven A, Dwyer B, Man TY, O'Duibhir E, Lewis PJS, Campana L, Kendall TJ, Bird TG, Tarrats N, Acosta JC, Boulter L, Forbes SJ.

Nat Commun. 2018 Mar 9;9(1):1020. doi: 10.1038/s41467-018-03299-5.

8.

Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?

Christen U, Hintermann E.

Front Immunol. 2018 Feb 16;9:163. doi: 10.3389/fimmu.2018.00163. eCollection 2018. Review.

9.

Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, Gumber S, Speck P, Elrod EJ, Burd EM, Kitchens WH, Magliocca JF, Adams AB, Weiss DS, Mohamadzadeh M, Grakoui A.

Gastroenterology. 2018 Jun;154(8):2178-2193. doi: 10.1053/j.gastro.2018.02.019. Epub 2018 Feb 15.

PMID:
29454797
10.

The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts.

Hov JR, Karlsen TH.

Semin Liver Dis. 2017 Nov;37(4):314-331. doi: 10.1055/s-0037-1608801. Epub 2017 Dec 22. Review.

PMID:
29272894
11.

Establishment of a surgical bile duct injection technique giving direct access to the bile ducts for studies of the murine biliary tree.

Berntsen NL, Fosby B, Valestrand L, Tan C, Reims HM, Schrumpf E, Karlsen TH, Line PD, Melum E.

Am J Physiol Gastrointest Liver Physiol. 2018 Mar 1;314(3):G349-G359. doi: 10.1152/ajpgi.00124.2017. Epub 2017 Dec 6.

PMID:
29212771
12.

The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.

Gitto S, Guarneri V, Sartini A, Andreone P.

Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):165-171. doi: 10.1080/17474124.2018.1399060. Epub 2017 Nov 3. Review.

PMID:
29082798
13.

Innate Lymphoid Cells in Intestinal Inflammation.

Geremia A, Arancibia-Cárcamo CV.

Front Immunol. 2017 Oct 13;8:1296. doi: 10.3389/fimmu.2017.01296. eCollection 2017. Review.

14.

Bile acid receptors in the biliary tree: TGR5 in physiology and disease.

Deutschmann K, Reich M, Klindt C, Dröge C, Spomer L, Häussinger D, Keitel V.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1319-1325. doi: 10.1016/j.bbadis.2017.08.021. Epub 2017 Aug 25. Review.

PMID:
28844960
15.

Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.

Chung BK, Karlsen TH, Folseraas T.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1390-1400. doi: 10.1016/j.bbadis.2017.08.020. Epub 2017 Aug 25. Review.

PMID:
28844951
16.

Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.

Moncsek A, Al-Suraih MS, Trussoni CE, O'Hara SP, Splinter PL, Zuber C, Patsenker E, Valli PV, Fingas CD, Weber A, Zhu Y, Tchkonia T, Kirkland JL, Gores GJ, Müllhaupt B, LaRusso NF, Mertens JC.

Hepatology. 2018 Jan;67(1):247-259. doi: 10.1002/hep.29464. Epub 2017 Nov 29.

17.

Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.

Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1374-1379. doi: 10.1016/j.bbadis.2017.07.023. Epub 2017 Jul 25. Review.

PMID:
28754453
18.

MicroRNAs and extracellular vesicles in cholangiopathies.

Olaizola P, Lee-Law PY, Arbelaiz A, Lapitz A, Perugorria MJ, Bujanda L, Banales JM.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1293-1307. doi: 10.1016/j.bbadis.2017.06.026. Epub 2017 Jul 13. Review.

PMID:
28711597
19.

Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Wu N, Meng F, Zhou T, Han Y, Kennedy L, Venter J, Francis H, DeMorrow S, Onori P, Invernizzi P, Bernuzzi F, Mancinelli R, Gaudio E, Franchitto A, Glaser S, Alpini G.

FASEB J. 2017 Oct;31(10):4305-4324. doi: 10.1096/fj.201700097R. Epub 2017 Jun 20.

20.

Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.

Kyritsi K, Meng F, Zhou T, Wu N, Venter J, Francis H, Kennedy L, Onori P, Franchitto A, Bernuzzi F, Invernizzi P, McDaniel K, Mancinelli R, Alvaro D, Gaudio E, Alpini G, Glaser S.

Am J Pathol. 2017 Jul;187(7):1551-1565. doi: 10.1016/j.ajpath.2017.03.013. Epub 2017 May 12.

Supplemental Content

Loading ...
Support Center